The role of cardiovascular magnetic resonance in the screening before the return-to-play of elite athletes after COVID-19: utility o futility?
Recent reports based on cardiovascular magnetic resonance (CMR) showed a wide range of prevalence of inflammatory heart diseases in COVID-19 convalescent athletes ranging from 0.4 up to 15%. These observations had an important impact in the field of sport cardiology opening an intense debate around the best possible screening strategy before the return-to-play. The diagnostic yield of CMR for detecting acute inflammatory disease is undebatable. However, the opportunity to use it in the screening protocol after COVID-19 has been questioned. Current evidence does not seem to support the routine use of CMR and the prescription of CMR should be based upon clinical indication.
© Copyright 2021 The Journal of Sports Medicine and Physical Fitness. Edizioni Minerva Medica. All rights reserved.
| Subjects: | |
|---|---|
| Notations: | biological and medical sciences |
| Tagging: | COVID-19 Coronavirus |
| Published in: | The Journal of Sports Medicine and Physical Fitness |
| Language: | English |
| Published: |
2021
|
| Online Access: | https://doi.org/10.23736/S0022-4707.21.12764-1 |
| Volume: | 61 |
| Issue: | 8 |
| Pages: | 1137-1143 |
| Document types: | article |
| Level: | advanced |